Genetic factors in the pathogenesis of cholangiocarcinoma

scientific article published on 17 June 2011

Genetic factors in the pathogenesis of cholangiocarcinoma is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000324688
P932PMC publication ID3696362
P698PubMed publication ID21691113

P50authorJohn WhittakerQ31694900
Catherine WilliamsonQ37830420
Stephen P. PereiraQ45264476
Simon D Taylor-RobinsonQ96164410
P2093author name stringHoward C Thomas
Jason H Wong
Peter H Dixon
Shahid A Khan
Michael H Chapman
Amar Sharif
Duncan R Spalding
Siobhan C McKay
Christopher A Wadsworth
P2860cites workBSEP: function and role in progressive familial intrahepatic cholestasisQ28211441
Role of multidrug resistance 3 deficiency in pediatric and adult liver disease: one gene for three diseasesQ28211448
Hepatocellular carcinoma in ten children under five years of age with bile salt export pump deficiencyQ28254452
Benign recurrent intrahepatic cholestasis type 2 is caused by mutations in ABCB11Q28276140
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancyQ28299892
Biliary tract cancers.Q33760399
Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document.Q33961881
Thorotrast-induced cholangiocarcinoma: case reportQ33963132
The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinomaQ33968668
Clinicopathologic review of 58 patients with biliary papillomatosisQ33975572
Polymorphism of glutathione S-transferase omega gene and risk of cancerQ33988280
Cholangiocarcinoma.Q33990595
Bile salt transporters: molecular characterization, function, and regulationQ34186800
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.Q35363829
DNA adducts, detected by 32P postlabelling, in human cholangiocarcinomaQ35595522
The epidemiology of cholangiocarcinomaQ35802314
Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria - an epidemiological investigationQ35991567
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control studyQ36154934
Enterohepatic transport of bile salts and genetics of cholestasisQ36173464
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom.Q37080976
Photodynamic therapy for cholangiocarcinoma: overview and new developmentsQ37529091
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in ChinaQ37617555
Genome-wide association analysis in primary sclerosing cholangitisQ39769745
Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United StatesQ44002826
A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosisQ44387840
Dietary exposures to food contaminants across the United StatesQ44406787
ABCB4 gene mutation-associated cholelithiasis in adultsQ44532958
Spontaneous cholecysto- and hepatolithiasis in Mdr2-/- mice: a model for low phospholipid-associated cholelithiasis.Q44749286
Association of the c.3972C>T variant of the multidrug resistance-associated protein 2 Gene (MRP2/ABCC2) with susceptibility to bile duct cancerQ47772854
BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitisQ48003458
Polymorphisms of 5,10-methylenetetrahydrofolate reductase (MTHFR C677T) and thymidylate synthase enhancer region (TSER) as a risk factor of cholangiocarcinoma in a Korean population.Q53581548
Association between genetic polymorphisms of CYP1A2, arylamine N-acetyltransferase 1 and 2 and susceptibility to cholangiocarcinoma.Q54663000
The association between cholangiooaroinoma and hereditary nonpolyposis colorectal carcinomaQ56032087
Long-term changes in the polychlorinated biphenyl content of United Kingdom soilsQ57159006
Prognostic Assessment of Three Single-Nucleotide Polymorphisms (GNB3825C>T,BCL2-938C>A,MCL1-386C>G) in Extrahepatic CholangiocarcinomaQ57205167
Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: A nationwide case-control studyQ58006620
Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control studyQ79835026
Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphismsQ79903673
Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinomaQ80200717
Endoscopic and surgical therapy for intrahepatic cholangiocarcinoma in the united states: a population-based studyQ80225398
Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patientsQ80406666
P433issue1
P921main subjectcholangiocarcinomaQ124292
P304page(s)93-97
P577publication date2011-06-17
P1433published inDigestive DiseasesQ15759019
P1476titleGenetic factors in the pathogenesis of cholangiocarcinoma
P478volume29

Reverse relations

cites work (P2860)
Q34396606Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease
Q37296197Atypical presentation of an advanced obstructive biliary cancer without jaundice.
Q30398077Challenges of liver cancer: Future emerging tools in imaging and urinary biomarkers
Q89558072Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort
Q53184261Cholangiocarcinoma: New Insights
Q38254730Effect of drug transporter pharmacogenetics on cholestasis
Q38305576Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility.
Q38099577Hepatobiliary anomalies associated with ABCB4/MDR3 deficiency in adults: a pictorial essay
Q92714519Hypercalcemia related to cholangiocellular carcinoma
Q37587269Incidence and mortality of primary liver cancer in England and Wales: changing patterns and ethnic variations
Q26998693Modern diagnostic approaches to cholangiocarcinoma
Q64085995Molecular Pathogenesis of Cholangiocarcinoma
Q38177235Roles of liver fluke infection as risk factor for cholangiocarcinoma
Q36388133The Roles of MicroRNA-122 Overexpression in Inhibiting Proliferation and Invasion and Stimulating Apoptosis of Human Cholangiocarcinoma Cells
Q55513254Translational Bioinformatics for Cholangiocarcinoma: Opportunities and Challenges.
Q42225304Upregulated expression of Mina53 in cholangiocarcinoma and its clinical significance

Search more.